Showing results (1301-1310 of 1,332) with videos related to

Sort By:
Pageof 134
Blood|July 16, 2021
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONEJesus San-Miguel, Hervé Avet-Loiseau, Bruno Paiva, et al.
The New England Journal of Medicine|December 13, 2017
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaMaría-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, et al.
Nature Plants|March 30, 2023
A complete gap-free diploid genome in Saccharum complex and the genomic footprints of evolution in the highly polyploid Saccharum genusTianyou Wang, Baiyu Wang, Xiuting Hua, et al.
JAMA|January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical TrialZiwei Zeng, Shuangling Luo, Hong Zhang, et al.
BMC Cancer|June 3, 2021
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trialStefan Knop, Maria-Victoria Mateos, Meletios A Dimopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Sequencing papaya X and Yh chromosomes reveals molecular basis of incipient sex chromosome evolutionJianping Wang, Jong-Kuk Na, Qingyi Yu, et al.
Nature Genetics|June 2, 2022
Genomic insights into the recent chromosome reduction of autopolyploid sugarcane Saccharum spontaneumQing Zhang, Yiying Qi, Haoran Pan, et al.
Blood|July 21, 2021
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIAMichele Cavo, Jesus San-Miguel, Saad Z Usmani, et al.
The Lancet Regional Health. Western Pacific|September 11, 2025
Developing a deep learning-based imaging diagnostic framework, PVDNet, for differentiating pulmonary artery sarcoma and pulmonary thromboembolism: a multi-center observational studyLinfeng Xi, Anqi Liu, Han Kang, et al.
Blood Advances|June 3, 2026
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUSSonja Zweegman, Thierry Facon, Vania Hungria, et al.
Pageof 134